68.85
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers - MSN
Disc Medicine prices upsized securities offering to raise total $250M - MSN
Disc Medicine plunges on FDA complete response letter for bitopertin - MSN
Will Insider 10b5-1 Sales and New ASCO Data Shift Disc Medicine's (IRON) Narrative? - Sahm
ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages ODDITY Tech Ltd. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action– ODD - GlobeNewswire Inc.
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Scott Coop
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
IRON Price Today: Disc Medicine, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Disc Medicine (NASDAQ:IRON) Upgraded at Wall Street Zen - MarketBeat
IRON Stock Price, Quote & Chart | DISC MEDICINE INC (NASDAQ:IRON) - ChartMill
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch - TipRanks
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are ... - Bluefield Daily Telegraph
IRON Investor News: If You Have Suffered Losses in Disc - GlobeNewswire
Disc Medicine to present myelofibrosis trial data at ASCO meeting By Investing.com - Investing.com India
Discipline and Rules-Based Execution in IRON Response - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.IRON - FinancialContent
Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge - Yahoo Finance
Disc Medicine to present myelofibrosis trial data at ASCO meeting - Investing.com
Disc Medicine, Inc. to Present RALLY-MF Trial Data on DISC-0974 at ASCO Annual Meeting 2026 - Quiver Quantitative
Disc Medicine announced that the Phase 2 clinical trial data of its drug DISC-0974 in patients with myelofibrosis-associated anemia (RALLY-MF) have been selected for an oral presentation at the annual meeting of the American Society of Clinical Oncology. - Bitget
Myelofibrosis anemia data lands ASCO oral presentation on June 2 - Stock Titan
Short Interest in Disc Medicine, Inc. (NASDAQ:IRON) Rises By 21.4% - MarketBeat
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates - GlobeNewswire
Insider Sell: Jean Franchi Sells Shares of Disc Medicine Inc (IR - GuruFocus
William Jacob Savage Sells 5,731 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Jean Franchi Sells 6,257 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine Insider Sold Shares Worth $380,449, According to a Recent SEC Filing - marketscreener.com
Disc Medicine CFO Franchi sells $460k in stock By Investing.com - Investing.com Canada
William Savage, chief medical officer, sells Disc Medicine shares for $380k - Investing.com Canada
Disc Medicine (NASDAQ: IRON) CMO sells 5,731 shares under 10b5-1 plan - Stock Titan
Disc Medicine (IRON) CFO sells 6,657 shares under 10b5-1 plan - Stock Titan
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inqui - GuruFocus
Press releases provided by CNW - Techaeris
IRON (NASDAQ: IRON) affiliate files Form 144, reports planned sale of 5,731 shares - Stock Titan
Panic Selling: Whats Disc Medicine Incs historical returnQuarterly Earnings Summary & Real-Time Buy Signal Notifications - baoquankhu1.vn
Volume Recap: Can Disc Medicine Inc outperform in the next rally2026 Sector Review & Breakout Confirmation Alerts - baoquankhu1.vn
Pullback Watch: Whats the beta of Disc Medicine Inc stock2026 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Behavioral Patterns of IRON and Institutional Flows - Stock Traders Daily
Gainers Report: Whats Disc Medicine Incs historical return2026 AllTime Highs & Capital Protection Trade Alerts - baoquankhu1.vn
Will Disc Medicine (IRON) Stock Grow in 2026 | Price at $66.45, Up 0.27%Trending Social Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Disc Medicine Hits 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, ... - Bluefield Daily Telegraph
Volatility Watch: Is Disc Medicine Inc stock good for income investors2026 Geopolitical Influence & Safe Entry Zone Identification - baoquankhu1.vn
Aberdeen Group plc Purchases 202,297 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON) Is Up 7.2% After Advancing Bitopertin Phase 3 Despite FDA Efficacy Concerns - simplywall.st
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):